BR0307236A - Processo para fabricação de compostos orgânicos - Google Patents
Processo para fabricação de compostos orgânicosInfo
- Publication number
- BR0307236A BR0307236A BR0307236-3A BR0307236A BR0307236A BR 0307236 A BR0307236 A BR 0307236A BR 0307236 A BR0307236 A BR 0307236A BR 0307236 A BR0307236 A BR 0307236A
- Authority
- BR
- Brazil
- Prior art keywords
- organic compounds
- manufacturing organic
- dihydroxyester
- ketoester
- hydroxy
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 150000002894 organic compounds Chemical class 0.000 title abstract 2
- 229910052783 alkali metal Inorganic materials 0.000 abstract 2
- -1 alkali metal salt Chemical class 0.000 abstract 2
- LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- SSVSTIGWSOEKDK-UHFFFAOYSA-N methoxyborane Chemical compound BOC SSVSTIGWSOEKDK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35231602P | 2002-01-28 | 2002-01-28 | |
| US38318802P | 2002-05-24 | 2002-05-24 | |
| PCT/EP2003/000804 WO2003064382A2 (en) | 2002-01-28 | 2003-01-27 | Process for the manufacture of organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0307236A true BR0307236A (pt) | 2004-12-07 |
Family
ID=27669055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0307236-3A BR0307236A (pt) | 2002-01-28 | 2003-01-27 | Processo para fabricação de compostos orgânicos |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6835838B2 (enExample) |
| EP (1) | EP1472227B1 (enExample) |
| JP (1) | JP2005516064A (enExample) |
| KR (2) | KR20100091267A (enExample) |
| CN (2) | CN1625550A (enExample) |
| AU (4) | AU2003239294B2 (enExample) |
| BR (1) | BR0307236A (enExample) |
| CA (1) | CA2472340A1 (enExample) |
| CO (1) | CO5601045A2 (enExample) |
| EC (1) | ECSP045202A (enExample) |
| IL (1) | IL162817A0 (enExample) |
| MX (1) | MXPA04007308A (enExample) |
| NO (1) | NO327363B1 (enExample) |
| NZ (3) | NZ554366A (enExample) |
| PL (1) | PL371383A1 (enExample) |
| RU (1) | RU2360903C2 (enExample) |
| SG (2) | SG161742A1 (enExample) |
| WO (1) | WO2003064382A2 (enExample) |
| ZA (1) | ZA200405239B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL159741A0 (en) | 2001-07-13 | 2004-06-20 | Astrazeneca Uk Ltd | Preparation of aminopyrimidine compounds |
| PT1466905E (pt) | 2001-11-14 | 2011-07-14 | Nissan Chemical Ind Ltd | Processo para a produção de éster do ácido oxo-heptenóico opticamente activo |
| DE60326819D1 (de) * | 2002-01-31 | 2009-05-07 | Novartis Ag | Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase |
| EP1539698B1 (en) * | 2002-09-20 | 2010-10-20 | Nissan Chemical Industries, Ltd. | Method for producing a 3,5-dihydroxy-6-heptenoate |
| EP3299359A1 (en) | 2003-02-12 | 2018-03-28 | Nissan Chemical Industries, Ltd. | Crystalline and amorphous forms of pitavastatin hemicalcium salt |
| US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
| TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
| CN1763015B (zh) * | 2004-10-22 | 2011-06-22 | 四川抗菌素工业研究所有限公司 | 一种罗舒伐他汀及其药用盐的制备方法及中间体 |
| GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
| GB0514078D0 (en) * | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
| WO2007125547A2 (en) * | 2006-05-03 | 2007-11-08 | Manne Satyanarayana Reddy | Novel process for statins and its pharmaceutically acceptable salts thereof |
| SI2086945T1 (sl) * | 2006-10-09 | 2016-05-31 | Msn Laboratories Private Limited | Novi postopek za pripravo statinov in njihovih farmacevtsko sprejemljivih soli |
| TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
| WO2010089770A2 (en) * | 2009-01-19 | 2010-08-12 | Msn Laboratories Limited | Improved process for the preparation of highly pure (3r,5s)-7-[2-cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl]-3,5-dihydroxy-6(e)-heptenoic acid and pharmaceutically acceptable salts thereof |
| RU2425034C1 (ru) * | 2010-01-11 | 2011-07-27 | Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ГОУ ВПО "КубГТУ") | Способ получения производных (e)-4-(6,7-диметокси-2-метил-3-хинолил)-3-бутен-2-она |
| WO2011086584A2 (en) | 2010-01-18 | 2011-07-21 | Msn Laboratories Limited | Improved process for the preparation of amide intermediates and their use thereof |
| EP2423195A1 (en) | 2010-07-26 | 2012-02-29 | LEK Pharmaceuticals d.d. | Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| US9034901B2 (en) | 2010-08-25 | 2015-05-19 | Cadila Healthcare Limited | Pitavastatin calcium and process for its preparation |
| EP2638013A4 (en) * | 2010-11-12 | 2014-03-26 | Hetero Research Foundation | NEW POLYMORPHS OF CALCIUM PIVASTATIN |
| WO2012140490A2 (en) | 2011-04-11 | 2012-10-18 | Aurobindo Pharma Limited | Process for preparing quinoline derivative |
| CN103755568B (zh) * | 2013-12-10 | 2015-10-28 | 江西科技师范大学 | IeodomycinA和B立体选择性合成方法 |
| JP6704916B2 (ja) | 2015-08-05 | 2020-06-03 | 株式会社エーピーアイ コーポレーション | ピタバスタチンカルシウムの製造方法 |
| CN108976168B (zh) * | 2017-06-02 | 2020-09-25 | 浙江京新药业股份有限公司 | 一种匹伐他汀半钙盐晶型及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| NZ230121A (en) * | 1988-08-29 | 1993-08-26 | Squibb & Sons Inc | Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels |
| JP3528186B2 (ja) * | 1991-06-24 | 2004-05-17 | 日産化学工業株式会社 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| JP3130342B2 (ja) * | 1991-10-04 | 2001-01-31 | 日産化学工業株式会社 | 動脈硬化性血管内膜肥厚抑制薬 |
| JP3554036B2 (ja) * | 1994-09-06 | 2004-08-11 | 宇部興産株式会社 | 光学活性な７−置換キノリル−３，５−ジヒドロキシ−ヘプト−６−エン酸エステル誘導体の製造方法 |
| PT1466905E (pt) * | 2001-11-14 | 2011-07-14 | Nissan Chemical Ind Ltd | Processo para a produção de éster do ácido oxo-heptenóico opticamente activo |
| EP2125754B1 (en) * | 2007-02-08 | 2012-04-11 | Aurobindo Pharma Limited | Process for preparation of rosuvastatin calcium |
-
2003
- 2003-01-24 US US10/350,615 patent/US6835838B2/en not_active Expired - Lifetime
- 2003-01-27 EP EP03734696.2A patent/EP1472227B1/en not_active Expired - Lifetime
- 2003-01-27 MX MXPA04007308A patent/MXPA04007308A/es active IP Right Grant
- 2003-01-27 JP JP2003564005A patent/JP2005516064A/ja active Pending
- 2003-01-27 CN CNA038028778A patent/CN1625550A/zh active Pending
- 2003-01-27 NZ NZ554366A patent/NZ554366A/en not_active IP Right Cessation
- 2003-01-27 RU RU2004126448/04A patent/RU2360903C2/ru not_active IP Right Cessation
- 2003-01-27 PL PL03371383A patent/PL371383A1/xx unknown
- 2003-01-27 CN CNB200510005170XA patent/CN100378081C/zh not_active Expired - Lifetime
- 2003-01-27 NZ NZ554367A patent/NZ554367A/en not_active IP Right Cessation
- 2003-01-27 AU AU2003239294A patent/AU2003239294B2/en not_active Ceased
- 2003-01-27 KR KR1020107017248A patent/KR20100091267A/ko not_active Ceased
- 2003-01-27 IL IL16281703A patent/IL162817A0/xx unknown
- 2003-01-27 KR KR10-2004-7011572A patent/KR20040077883A/ko not_active Ceased
- 2003-01-27 SG SG200605094-2A patent/SG161742A1/en unknown
- 2003-01-27 BR BR0307236-3A patent/BR0307236A/pt not_active Application Discontinuation
- 2003-01-27 CA CA002472340A patent/CA2472340A1/en not_active Abandoned
- 2003-01-27 NZ NZ534136A patent/NZ534136A/en not_active IP Right Cessation
- 2003-01-27 SG SG200605092-6A patent/SG157225A1/en unknown
- 2003-01-27 WO PCT/EP2003/000804 patent/WO2003064382A2/en not_active Ceased
-
2004
- 2004-07-01 ZA ZA2004/05239A patent/ZA200405239B/en unknown
- 2004-07-14 US US10/891,357 patent/US7572917B2/en not_active Expired - Fee Related
- 2004-07-22 EC EC2004005202A patent/ECSP045202A/es unknown
- 2004-08-06 CO CO04076720A patent/CO5601045A2/es not_active Application Discontinuation
- 2004-08-27 NO NO20043586A patent/NO327363B1/no not_active IP Right Cessation
-
2006
- 2006-10-03 AU AU2006225206A patent/AU2006225206B2/en not_active Ceased
- 2006-10-03 AU AU2006225205A patent/AU2006225205B2/en not_active Ceased
-
2009
- 2009-07-02 US US12/497,001 patent/US20090299065A1/en not_active Abandoned
- 2009-08-12 AU AU2009208129A patent/AU2009208129A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0307236A (pt) | Processo para fabricação de compostos orgânicos | |
| BR0017030A (pt) | Derivados de tiazolilamida | |
| BRPI0407967A (pt) | processo de uma etapa para a preparação de derivados anticonvulsivantes | |
| EA200300211A1 (ru) | Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств | |
| CL2010000284A1 (es) | Procedimientos para la preparacion de 4-(2-cianoetenil)-2,6-dimetilanilina a partir de 2,6-dimetil-4-sustituida-anilina. (divisional de solicitud 2003-01598) | |
| BR0112538A (pt) | Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos | |
| BRPI0416534A (pt) | composições multiparticuladas com estabilidade melhorada | |
| BRPI0108990B8 (pt) | processo para preparação de derivados de pirimidona com atividade antifungos | |
| BR0215097A (pt) | Processo para fazer o composto da fórmula e composto da fórmula | |
| BR0012371A (pt) | Sistema de caixa de câmbio com dispositivo de câmbio | |
| BR0114437A (pt) | Derivados de acido propiÈnico | |
| NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
| BR0208861A (pt) | Processo para a preparação de um composto, e, composto | |
| BRPI0412835A (pt) | processo para preparação de uma solução de alfa-1-antitripsina | |
| BR0113259A (pt) | Processo para a preparação de um composto, composto e processo para a preparação de compostos | |
| TW200716582A (en) | Process for making a pharmaceutical compound | |
| BR0311699A (pt) | Processo para a decomposição de hidroperóxido de cicloexila | |
| BR0210894A (pt) | Derivados de benzo(g) quinolina | |
| BRPI0507979A (pt) | processo para preparação de um composto | |
| BR0009453A (pt) | Processo para a preparação de um composto | |
| BRPI0409235A (pt) | processo para a produção de sal de amÈnio do ácido 2-hidróxi-4-metiltiobutìrico | |
| BRPI0407448A (pt) | Processo quìmico | |
| BR0209842A (pt) | Processo para a preparação de imipenem | |
| BR0314306A (pt) | Processo para produção de um álcool pela hidrogenação de um aldeìdo alifático sobre um catalisador | |
| BRPI0411717A (pt) | processo para a preparação de acilsulfamoibenzamidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
| B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |